The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Couldn't make yesterday's live presentation with YOURGENE? Catch up here:
https://www.youtube.com/watch?v=6lKZcwVtSB8
I'm sorry,it's old article...Apr 22 2021
Yes Frankie, I notice it also!
It's Hussam almawal on Twetter. He wrote in response to a friend's tweet: date 10 September
"...I have got a new job as Operational manager at Yourgene, and I'm setting a new Live virus lab (COVID)'''"
91. Domestic sequencing capacity has been enhanced in 2021 and will continue to
increase over the coming months, enabling a higher number of PCR positive cases to
undergo whole genome sequencing, improving the detection of variants. In addition,
wastewater testing and the use of new technology, such as genotype assay testing,
have been expanded as an additional surveillance function to detect variants and
outbreaks.
95. The Government will also continue to provide access to:
a. The COVID-19 Contain Framework which clarifies the national support and
infrastructure available to local authorities.
b. National support for an enhanced response in areas with particularly
challenging disease situations. This support includes targeted surge testing,
vaccination logistical support, logistics support, and national funding to enhance
local communications efforts.
...and more
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1017404/COVID-19-response-autumn-and-winter-plan-2021.pdf
YGEN), a leading international molecular diagnostic group, announces that a Contract Award Notice has been published in relation to its contract with the Department of Health & Social Care ("DHSC") for the provision of laboratory capacity to the NHS Test and Trace Programme for COVID-19 testing, as announced on 19 August 2021 (RNS: 2020J).
The disclosure can be seen here:
https://www.contractsfinder.service.gov.uk/notice/b7ee1f61-0d00-4038-a45a-06eeb5c5aba9?origin=SearchResults&p=1
As previously announced, the contract is the first to come from the National Microbiology Framework Lot wins announced earlier this year, using Yourgene's high throughput automated COVID-19 services testing laboratory in Citylabs 1.0, Manchester.
The final contract notice value of £34m is the maximum estimated value of the contract. Actual value will depend on services purchased and there is no committed spend under the contract. However, the Company confirms that samples are already being processed as part of the contract.
Yourgene will provide an update for shareholders on first half trading on the morning of the Annual General Meeting due to take place on Tuesday 28 September 2021.
Thanks Steve67! Excellent find!
https://www.business-live.co.uk/technology/greater-manchester-tech-50-numbers-21488395
AIM listed Yourgene Health [LON:YGEN] has this morning advised the market that its Manchester laboratory has received ISO accreditation for its COIVD-19 testing and sequencing services. In addition to validating certificates in the UK, this also means that the company obtains global accreditation, valid in 80 countries worldwide. With no sign that testing protocols will abate any time soon, this news could help shares push back toward levels last seen eleven months ago.
https://www.thearmchairtrader.com/888-holdings-pphe-hotel-group-and-yourgene-health/
Yourgene Genomic Services receive ISO 15189:2012 accreditation !!!
Our CEO Rupert Verco visited the drill site last week and recorded a short message for investors from our Clarke prospect where Cobra had stunning results in last year’s drill campaign including 31 metres at over 3 grams of gold per https://mobile.twitter.com/Cobra_Resources/status/1430109465106395143
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, welcomes the announcement yesterday from the Department of Health and Social Care ("DHSC") that private COVID-19 testing companies will be removed from the GOV.UK list if they advertise misleading prices. 82 providers, making up around 18% of companies listed, have been identified as displaying lower prices on GOV.UK than are available on their website at the point of checkout.
MyHealthChecked welcomes a greater degree of Government scrutiny of private testing companies included on the UK Government list of approved providers of COVID-19 testing service for travel. Not only does MyHealthChecked provide clear, transparent and market competitive pricing for compliant testing for international travel tests, but also ensures a high standard of service and robust laboratory capacity planning methods to ensure customer needs are met.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:
"This is very good news for the public as it will only improve the calibre of COVID-19 testing services available, and ensure pricing is transparent whilst driving an improvement in quality of service from those approved companies included on the Government list. At MyHealthChecked we have always been clear on pricing. We have made pricing information simple, the nasal swab process is simple and our customer care is second to none, with tens of thousands of satisfied customers as a result of our service.
"Sadly, we hear reports of other testing companies on the Government list also falling short when it comes to maintaining high standards across other aspects of their service and we welcome the Health Secretary's call for the competition watchdog to investigate concerns about inadequate service.
"We agree with the Government that only the most compliant, reliable and efficient testing service providers should be on that list and we take great pride that we can fulfil our obligations for laboratory capacity, achievement of turnaround times at our labs, and clear pricing structures across the portfolio."
MyHealthChecked's services have been included as one of the suppliers on the Government list with "Fit to Fly", "Test to Release" and "Days 2 and 8" testing, and the Company has established a key commercial partnership with Boots UK Limited ("Boots"). The MyHealthChecked COVID-19 testing service is available via www.boots.com and across over 500 Boots stores in Great Britain.
The MyHealthChecked™ COVID-19 at-home nasal swab kit and PCR laboratory testing service utilises the Company's own laboratory in Manchester, together with its partner laboratory provided by Yourgene Health plc. The laboratories used as part of the MyHealthChecked™ COVID-19 testing service all deliver a proficient and high-quality service.
In a bid to transform the safety of patient treatment, the world of molecular diagnostics is broadening its reach as companies such as Yourgene Health expand into reproductive health, precision medicine and infectious diseases. Based at the Citylabs campus in Manchester, the company has developed its DPYD Assay to identify patients with Dihydropyrimidine dehydrogenase (DPD) enzyme deficiency, which can increase the risk of severe or even fatal toxicity from 5-fluorouracil chemotherapy agents used to treat certain cancers.
https://www.labnews.co.uk/article/2031451/driving-precision-medicine-into-frontline-healthcare
Not at all! We are together in Ygen, I think that now we will go north only
Join YOURGENE HEALTH PLC's proceedings TODAY at 2:00pm, for all the company insights
Register link https://www.investormeetcompany.com/yourgene-health-plc/register-investor?utm_source=TWITTER&utm_medium=TWITTER&utm_campaign=YGEN
Biotech group looks West for future growth opportunities
https://www.thebusinessdesk.com/northwest/news/2083594-biotech-group-looks-west-for-future-growth-opportunities/
Strong start for Yourgene
https://www.insidermedia.com/news/north-west/strong-start-for-yourgene
Online exhibition - opened on 7/19-7/28
Onsite Exhibition has been rescheduled to 11/4-7, 2021
https://expo.bioasiataiwan.com/en/newsDetail.asp?serno=3160
https://expo.bioasiataiwan.com/en/visitorExhibitorDetail.asp?comNo=280794&sno=172158
The UK Pavilion at BIO Asia Taiwan 2021 is managed by British Office Taipei. We promote: trade, investment, and scientific collaboration between the UK and Taiwan. For this year’s event, focus areas will be Digital Health (AI, telemedicine, wearables, assistive technologies); Precision Medicine (Gene and Cell therapy); and Advanced Therapies. Companies presenting at the UK pavilion: Yourgene Health, Oxford Instruments, GSK, AstraZeneca, Rosemont Pharma, Halewood Chemicals, Hughes Healthcare.